Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
Resnik
David B
DB
East Carolina University.
DeVille
Kenneth A
KA
D000881:Anthrax / Q000188:drug therapy / Q000517:prevention & control; D023482:Bioterrorism; D002939:Ciprofloxacin / Q000600:supply & distribution / Q000627:therapeutic use; D035881:Compensation and Redress / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D026689:Ethical Analysis; D028663:Ethical Theory; D035082:Federal Government; D005610:Freedom; D006801:Humans; D018973:Intellectual Property; D038622:Internationality; D008004:Licensure / Q000331:legislation & jurisprudence*; D010330:Patents as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence*; D004364:Pharmaceutical Preparations / Q000191:economics / Q000600:supply & distribution; D017149:Private Sector; D011634:Public Health; D011640:Public Policy; D017150:Public Sector; D012109:Research Support as Topic; D012935:Social Justice; D013997:Time Factors; D014481:United States
D004364:Pharmaceutical Preparations; D002939:Ciprofloxacin